Home
On-Demand
Industrie
FAQ
Login MyUpdate
Home
On-Demand
Industrie
FAQ
Login MyUpdate
Schlagwort
Vedolizumab
CED II
CED II
Divertikulitis
/
Eisen-Carboxymaltose
/
Etrasimod
/
GETAID-Studie
/
Hypophosphatämie
/
Koronararterien-Kalk
/
Mesalazin
/
Mirikizumab
/
Obefazimod
/
Olamkicept
/
Pankolitis ulcerosa
/
Proktokolektomie
/
Tofacitinib
/
Ustekinumab
/
Vedolizumab
CED I
CED I
Biologikatherapie
/
Darmerkrankungen
/
EVOLVE-Studie
/
IFX-Therapie
/
Ileozökalresektion
/
Kono-S-Anastomose
/
Mikrobiom-Analysen
/
Morbus Crohn
/
REACT-2-Studie
/
Risankizumab
/
RUN-CD-Studie
/
SEAVUE-Studie
/
STARDUST-Studie
/
Ustekinumab
/
Vedolizumab
